Global and Japan Long-Acting Injectables Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Small and Middle Sized Molecule
  • 1.2.3 Large Sized Molecule
• 1.3 Market by Application
  • 1.3.1 Global Long-Acting Injectables Market Share by Application: 2020 VS 2026
  • 1.3.2 Schizophrenia
  • 1.3.3 Other Psychotic Disorders
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Long-Acting Injectables Market Perspective (2015-2026)
• 2.2 Global Long-Acting Injectables Growth Trends by Regions
  • 2.2.1 Long-Acting Injectables Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Long-Acting Injectables Historic Market Share by Regions (2015-2020)
  • 2.2.3 Long-Acting Injectables Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Long-Acting Injectables Players by Market Size
  • 3.1.1 Global Top Long-Acting Injectables Players by Revenue (2015-2020)
  • 3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2015-2020)
• 3.2 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Long-Acting Injectables Revenue
• 3.4 Global Long-Acting Injectables Market Concentration Ratio
  • 3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2019
• 3.5 Key Players Long-Acting Injectables Area Served
• 3.6 Key Players Long-Acting Injectables Product Solution and Service
• 3.7 Date of Enter into Long-Acting Injectables Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Long-Acting Injectables Breakdown Data by Type (2015-2026)

• 4.1 Global Long-Acting Injectables Historic Market Size by Type (2015-2020)
• 4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2021-2026)

5 Long-Acting Injectables Breakdown Data by Application (2015-2026)

• 5.1 Global Long-Acting Injectables Historic Market Size by Application (2015-2020)
• 5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Long-Acting Injectables Market Size (2015-2026)
• 6.2 North America Long-Acting Injectables Market Size by Type (2015-2020)
• 6.3 North America Long-Acting Injectables Market Size by Application (2015-2020)
• 6.4 North America Long-Acting Injectables Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Long-Acting Injectables Market Size (2015-2026)
• 7.2 Europe Long-Acting Injectables Market Size by Type (2015-2020)
• 7.3 Europe Long-Acting Injectables Market Size by Application (2015-2020)
• 7.4 Europe Long-Acting Injectables Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Long-Acting Injectables Market Size (2015-2026)
• 8.2 China Long-Acting Injectables Market Size by Type (2015-2020)
• 8.3 China Long-Acting Injectables Market Size by Application (2015-2020)
• 8.4 China Long-Acting Injectables Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Long-Acting Injectables Market Size (2015-2026)
• 9.2 Japan Long-Acting Injectables Market Size by Type (2015-2020)
• 9.3 Japan Long-Acting Injectables Market Size by Application (2015-2020)
• 9.4 Japan Long-Acting Injectables Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Long-Acting Injectables Market Size (2015-2026)
• 10.2 Southeast Asia Long-Acting Injectables Market Size by Type (2015-2020)
• 10.3 Southeast Asia Long-Acting Injectables Market Size by Application (2015-2020)
• 10.4 Southeast Asia Long-Acting Injectables Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Eli Lilly
  • 11.1.1 Eli Lilly Company Details
  • 11.1.2 Eli Lilly Business Overview
  • 11.1.3 Eli Lilly Long-Acting Injectables Introduction
  • 11.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2015-2020))
  • 11.1.5 Eli Lilly Recent Development
• 11.2 Pfizer
  • 11.2.1 Pfizer Company Details
  • 11.2.2 Pfizer Business Overview
  • 11.2.3 Pfizer Long-Acting Injectables Introduction
  • 11.2.4 Pfizer Revenue in Long-Acting Injectables Business (2015-2020)
  • 11.2.5 Pfizer Recent Development
• 11.3 GlaxoSmithKline
  • 11.3.1 GlaxoSmithKline Company Details
  • 11.3.2 GlaxoSmithKline Business Overview
  • 11.3.3 GlaxoSmithKline Long-Acting Injectables Introduction
  • 11.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2015-2020)
  • 11.3.5 GlaxoSmithKline Recent Development
• 11.4 Johnson & Johnson
  • 11.4.1 Johnson & Johnson Company Details
  • 11.4.2 Johnson & Johnson Business Overview
  • 11.4.3 Johnson & Johnson Long-Acting Injectables Introduction
  • 11.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2015-2020)
  • 11.4.5 Johnson & Johnson Recent Development
• 11.5 Lupin Limited
  • 11.5.1 Lupin Limited Company Details
  • 11.5.2 Lupin Limited Business Overview
  • 11.5.3 Lupin Limited Long-Acting Injectables Introduction
  • 11.5.4 Lupin Limited Revenue in Long-Acting Injectables Business (2015-2020)
  • 11.5.5 Lupin Limited Recent Development
• 11.6 Zogenix
  • 11.6.1 Zogenix Company Details
  • 11.6.2 Zogenix Business Overview
  • 11.6.3 Zogenix Long-Acting Injectables Introduction
  • 11.6.4 Zogenix Revenue in Long-Acting Injectables Business (2015-2020)
  • 11.6.5 Zogenix Recent Development
• 11.7 DURECT
  • 11.7.1 DURECT Company Details
  • 11.7.2 DURECT Business Overview
  • 11.7.3 DURECT Long-Acting Injectables Introduction
  • 11.7.4 DURECT Revenue in Long-Acting Injectables Business (2015-2020)
  • 11.7.5 DURECT Recent Development
• 11.8 Medincel
  • 11.8.1 Medincel Company Details
  • 11.8.2 Medincel Business Overview
  • 11.8.3 Medincel Long-Acting Injectables Introduction
  • 11.8.4 Medincel Revenue in Long-Acting Injectables Business (2015-2020)
  • 11.8.5 Medincel Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer